In France, tuberculosis has been a reportable disease since 1964. Until now, mandatory reporting has been the sole source of information on the epidemiological situation. Two...

The National Reference Center for Mycobacterial Resistance to Antituberculosis Drugs (CNR-RMA) works alongside other national agencies to monitor mycobacterial resistance to antibiotics....

In Western European countries, as in other countries where the incidence of tuberculosis is low, the disease is primarily a problem in large cities. London, with a population of...

The Strasbourg International Vaccination and Travel Advisory Center sees approximately 7,000 people each year, 4,500 of whom come for a yellow fever vaccination. During a consultation,...

This article presents an epidemiological and virological overview of influenza activity in mainland France during the 2007–2008 season. Methods - The article is based on community-based...

Introduction - In 2001, there were no data on mortality related to HCV and HBV in metropolitan France. The Center for Epidemiology of Medical Causes of Death (CépiDc-Inserm) initiated a...

The results presented here pertain to cases of active tuberculosis reported in France during 2006 under mandatory reporting requirements. In 2006, the number of reported cases of active...

Introduction. Since 1995, no data on the prevalence of tuberculosis in prisons have been published in France, and no evaluation of systematic screening upon admission has been conducted....

For more than 20 years, the annual incidence rate of invasive meningococcal disease (IMD) in France has ranged from 1 to 2 cases per 105 inhabitants. It increased between 1996 and 2003...